Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43026 (
lipopolysaccharide
)
62,215
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have demonstrated that CD45, a receptor-type protein tyrosine phosphatase, selectively regulates IgG production at the generative phase of precursors of IgG producers whereas
Lyb-2
regulates IgG1 production induced by IL-4 in
lipopolysaccharide
(
LPS
)-activated B cells by acting on the generation of IgG1 precursor cells. These results point to an interesting possibility that both CD45 and
Lyb-2
mediate a critical regulatory step(s) in IgG class switching. The present study was conducted to examine this possibility by elucidating the molecular mechanisms whereby CD45 and
Lyb-2
control IgG synthesis in B cells activated by
LPS
and IL-4. Northern blot analysis showed that steady-state levels of C gamma 3, C gamma 2b and C gamma 1, but not Cmu, mRNA in
LPS
-activated B cells were reduced approximately 3- to 5-fold by CD45 mAb, and that the C gamma 1 mRNA level in B cells activated by
LPS
and IL-4 was significantly decreased by
Lyb-2
mAb and CD45 mAb. Further, CD45 mAb inhibited expression of germline gamma 2b and gamma 3 transcripts induced by
LPS
and germline gamma 1 transcript expression induced by IL-4 plus
LPS
, but caused no inhibition in IL-4-induced germline gamma 1 transcript expression. In contrast,
Lyb-2
mAb did not exert any inhibitory effect on the generation of germline gamma 1 transcripts induced by IL-4 and
LPS
or by IL-4 alone.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Regulation of lipopolysaccharide- and IL-4-induced immunoglobulin heavy chain gene activation: differential roles for CD45 and Lyb-2. 153 9
The unique murine lymphocyte differentiation antigen, Lp-3, with a mol. wt of approximately 125 kd, was found using a rat monoclonal antibody. The Lp-3 antigen was distributed on a wide variety of myeloid, T cell, and B cell lineages in mice. However, the expression was only found in B cells at certain stages of differentiation. The pre-B and virgin B cells in the bone marrow from 2-month-old BALB/c mice were weakly positive for Lp-3, while the resting B cells in the spleen and lymph node were Lp-3 negative. In contrast, the majority of B cells in the peritoneal cavity, mostly Ly-1 (CD5) B cells, had a brighter fluorescence for Lp-3 than did bone marrow B cells. The Lp-3 antigen could be induced in a high density in approximately one-half of
lipopolysaccharide
-stimulated, large, blastic spleen B cells. Cell cycle analysis showed that Lp-3 is an early B cell activation antigen which is first expressed at the G1A phase of the cell cycle. Therefore this novel
B cell differentiation antigen
will be useful for differentiating pre-B and virgin B cells in the bone marrow, resting B cells, and a population of activated B cells in the periphery. In contrast to findings in BALB/c mice, there was an elevated population of B cells with a bright Lp-3 expression in the spleen of autoimmune-prone NZB x NZW F1 mice.
...
PMID:The novel murine B cell differentiation antigen Lp-3. 248 44
The
Lyb-2
system of the mouse is a B cell-specific cell surface molecule encoded by a gene on chromosome 4. We have previously reported that
Lyb-2
is involved in an early phase of B cell differentiation, specifically a process mediated by B cell stimulatory factor-1 (BSF-1) or-interleukin 4. It is thus very important to define the functional role and structural features of
Lyb-2
molecule for the understanding of the regulatory mechanisms of B cell activation initiated by BSF-1. In our attempt to resolve these issues, we found that
Lyb-2
antibody inhibits activation processes mediated by BSF-1 such as induction of Ia antigen on the B cell surface and of IgG1 production in
lipopolysaccharide
-activated B cells, suggesting that
Lyb-2
molecule participates in a signaling event triggered by the binding of BSF-1 to its receptor. In the structural analysis, we found that in contrast to previous reports,
Lyb-2
is not a monomer of 45 kilodaltons (kDa) but is composed of two components with molecular weight of 45 kDa and 105 kDa. Reduced and nonreduced two-dimensional electrophoresis analysis further revealed that
Lyb-2
molecules are present on the B cell surface in two forms, a disulfide-bonded heterodimer of 45 kDa and 105 kDa chains and a 45 kDa homatrimer. How the structural uniqueness of
Lyb-2
is related to its functional expression remains to be determined.
...
PMID:[Functional and structural analysis of the Lyb-2 system]. 278 50
We have identified two important molecules involved in the regulation of B cell differentiation, namely
Lyb-2
and Ly-5. To gain further insight into the function of these two molecules, we examined the effect of monoclonal
Lyb-2
and Ly-5 antibodies on
lipopolysaccharide
(
LPS
)-induced B cell growth and maturation. We found that
Lyb-2
antibody does not have any effect on
LPS
-induced proliferation and on polyclonal IgM or total IgG responses. On the other hand, although Ly-5 antibody did not affect proliferation and polyclonal IgM responses, it strongly inhibited polyclonal IgG responses, presumably by direct action on B cells. This inhibition was not caused by direct suppressive effect of Ly-5 antibody or Fc receptor-mediated negative signaling. To exert maximal inhibitory effect, Ly-5 antibody had to be added to the culture during the initial 48 hr. However, the presence of Ly-5 antibody during the first 2 days did not cause a significant inhibition. It is thus likely that Ly-5 plays a critical role in the regulation of
LPS
-induced B cell maturation into IgG-secreting cells at a phase starting within 48 hr after
LPS
stimulation and continuing thereafter.
...
PMID:Selective inhibition of lipopolysaccharide-induced polyclonal IgG response by monoclonal Ly-5 antibody. 348 73